nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—Mesalazine—Crohn's disease	0.424	1	CrCtD
Salicylic acid—Salicylate-sodium—Mesalazine—Crohn's disease	0.07	0.277	CrCrCtD
Salicylic acid—Diflunisal—Mesalazine—Crohn's disease	0.07	0.277	CrCrCtD
Salicylic acid—Aminosalicylic Acid—Mesalazine—Crohn's disease	0.07	0.277	CrCrCtD
Salicylic acid—PTGS2—Crohn's disease	0.0638	0.529	CbGaD
Salicylic acid—ALB—Crohn's disease	0.0568	0.471	CbGaD
Salicylic acid—Salicylamide—Mesalazine—Crohn's disease	0.0427	0.169	CrCrCtD
Salicylic acid—PTGS2—Balsalazide—Crohn's disease	0.0352	0.197	CbGbCtD
Salicylic acid—PTGS1—Balsalazide—Crohn's disease	0.0298	0.167	CbGbCtD
Salicylic acid—PTGS2—Mesalazine—Crohn's disease	0.0282	0.158	CbGbCtD
Salicylic acid—PTGS1—Mesalazine—Crohn's disease	0.0238	0.133	CbGbCtD
Salicylic acid—SLC22A8—Mercaptopurine—Crohn's disease	0.0205	0.115	CbGbCtD
Salicylic acid—PTGS2—Sulfasalazine—Crohn's disease	0.0157	0.0881	CbGbCtD
Salicylic acid—PTGS1—Sulfasalazine—Crohn's disease	0.0133	0.0744	CbGbCtD
Salicylic acid—ALB—Prednisone—Crohn's disease	0.00794	0.0444	CbGbCtD
Salicylic acid—ABCB1—Prednisone—Crohn's disease	0.00415	0.0232	CbGbCtD
Salicylic acid—Niacin—SLC22A5—Crohn's disease	0.000361	0.215	CrCbGaD
Salicylic acid—Duodenal ulcer—Mesalazine—Crohn's disease	0.000258	0.0672	CcSEcCtD
Salicylic acid—Aminosalicylic Acid—MPO—Crohn's disease	0.000223	0.133	CrCbGaD
Salicylic acid—Upset stomach—Mesalazine—Crohn's disease	0.00019	0.0496	CcSEcCtD
Salicylic acid—Burning sensation—Mesalazine—Crohn's disease	0.000179	0.0468	CcSEcCtD
Salicylic acid—Mesalazine—MPO—Crohn's disease	0.000175	0.104	CrCbGaD
Salicylic acid—Salicylate-sodium—PTGS2—Crohn's disease	0.00013	0.0772	CrCbGaD
Salicylic acid—Skin exfoliation—Mesalazine—Crohn's disease	0.000119	0.031	CcSEcCtD
Salicylic acid—Ecchymosis—Mesalazine—Crohn's disease	0.000113	0.0294	CcSEcCtD
Salicylic acid—Deafness—Mesalazine—Crohn's disease	0.000101	0.0264	CcSEcCtD
Salicylic acid—Lethargy—Mesalazine—Crohn's disease	9.23e-05	0.0241	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS2—Crohn's disease	8.88e-05	0.0529	CrCbGaD
Salicylic acid—Diflunisal—PTGS2—Crohn's disease	8.35e-05	0.0498	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS2—Crohn's disease	8.35e-05	0.0498	CrCbGaD
Salicylic acid—Abdominal pain upper—Mesalazine—Crohn's disease	8.26e-05	0.0215	CcSEcCtD
Salicylic acid—Abdominal discomfort—Azathioprine—Crohn's disease	8.23e-05	0.0215	CcSEcCtD
Salicylic acid—Oedema—Mercaptopurine—Crohn's disease	8.19e-05	0.0214	CcSEcCtD
Salicylic acid—Magnesium salicylate—ALB—Crohn's disease	7.91e-05	0.0472	CrCbGaD
Salicylic acid—Asthma—Mesalazine—Crohn's disease	7.82e-05	0.0204	CcSEcCtD
Salicylic acid—Anorexia—Mercaptopurine—Crohn's disease	7.81e-05	0.0204	CcSEcCtD
Salicylic acid—Salsalate—PTGS2—Crohn's disease	7.55e-05	0.045	CrCbGaD
Salicylic acid—Abdominal discomfort—Mesalazine—Crohn's disease	7.49e-05	0.0195	CcSEcCtD
Salicylic acid—Meclofenamic acid—PTGS2—Crohn's disease	7.44e-05	0.0444	CrCbGaD
Salicylic acid—Diflunisal—ALB—Crohn's disease	7.44e-05	0.0444	CrCbGaD
Salicylic acid—Decreased appetite—Mercaptopurine—Crohn's disease	7.12e-05	0.0186	CcSEcCtD
Salicylic acid—Weight increased—Mesalazine—Crohn's disease	7.11e-05	0.0186	CcSEcCtD
Salicylic acid—Epistaxis—Mesalazine—Crohn's disease	6.57e-05	0.0171	CcSEcCtD
Salicylic acid—Mesalazine—PTGS2—Crohn's disease	6.55e-05	0.0391	CrCbGaD
Salicylic acid—Erythema multiforme—Azathioprine—Crohn's disease	6.5e-05	0.0169	CcSEcCtD
Salicylic acid—Skin exfoliation—Prednisone—Crohn's disease	6.29e-05	0.0164	CcSEcCtD
Salicylic acid—Hepatitis—Mesalazine—Crohn's disease	6.26e-05	0.0163	CcSEcCtD
Salicylic acid—Oesophagitis—Prednisone—Crohn's disease	6.02e-05	0.0157	CcSEcCtD
Salicylic acid—Ecchymosis—Prednisone—Crohn's disease	5.96e-05	0.0155	CcSEcCtD
Salicylic acid—Erythema multiforme—Mesalazine—Crohn's disease	5.92e-05	0.0154	CcSEcCtD
Salicylic acid—Tinnitus—Mesalazine—Crohn's disease	5.83e-05	0.0152	CcSEcCtD
Salicylic acid—Mefenamic acid—PTGS2—Crohn's disease	5.79e-05	0.0345	CrCbGaD
Salicylic acid—Acetylsalicylic acid—PTGS2—Crohn's disease	5.64e-05	0.0336	CrCbGaD
Salicylic acid—Diarrhoea—Mercaptopurine—Crohn's disease	5.6e-05	0.0146	CcSEcCtD
Salicylic acid—Erythema—Mesalazine—Crohn's disease	5.45e-05	0.0142	CcSEcCtD
Salicylic acid—Dysgeusia—Mesalazine—Crohn's disease	5.33e-05	0.0139	CcSEcCtD
Salicylic acid—Vomiting—Mercaptopurine—Crohn's disease	5.21e-05	0.0136	CcSEcCtD
Salicylic acid—Rash—Mercaptopurine—Crohn's disease	5.16e-05	0.0135	CcSEcCtD
Salicylic acid—Dermatitis—Mercaptopurine—Crohn's disease	5.16e-05	0.0135	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ALB—Crohn's disease	5.02e-05	0.03	CrCbGaD
Salicylic acid—Lethargy—Prednisone—Crohn's disease	4.88e-05	0.0127	CcSEcCtD
Salicylic acid—Nausea—Mercaptopurine—Crohn's disease	4.87e-05	0.0127	CcSEcCtD
Salicylic acid—Confusional state—Mesalazine—Crohn's disease	4.48e-05	0.0117	CcSEcCtD
Salicylic acid—Oedema—Mesalazine—Crohn's disease	4.45e-05	0.0116	CcSEcCtD
Salicylic acid—Anorexia—Mesalazine—Crohn's disease	4.24e-05	0.0111	CcSEcCtD
Salicylic acid—Feeling abnormal—Azathioprine—Crohn's disease	4.02e-05	0.0105	CcSEcCtD
Salicylic acid—Somnolence—Mesalazine—Crohn's disease	3.95e-05	0.0103	CcSEcCtD
Salicylic acid—Dyspepsia—Mesalazine—Crohn's disease	3.91e-05	0.0102	CcSEcCtD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.87e-05	0.00212	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.87e-05	0.00212	CbGpPWpGaD
Salicylic acid—Decreased appetite—Mesalazine—Crohn's disease	3.86e-05	0.0101	CcSEcCtD
Salicylic acid—Constipation—Mesalazine—Crohn's disease	3.8e-05	0.00992	CcSEcCtD
Salicylic acid—Pain—Mesalazine—Crohn's disease	3.8e-05	0.00992	CcSEcCtD
Salicylic acid—AKR1C1—Signaling Pathways—MLN—Crohn's disease	3.78e-05	0.00207	CbGpPWpGaD
Salicylic acid—Weight increased—Prednisone—Crohn's disease	3.76e-05	0.00982	CcSEcCtD
Salicylic acid—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.76e-05	0.00206	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	3.75e-05	0.00205	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	3.68e-05	0.00202	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	3.67e-05	0.00201	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—LTF—Crohn's disease	3.67e-05	0.00201	CbGpPWpGaD
Salicylic acid—Feeling abnormal—Mesalazine—Crohn's disease	3.66e-05	0.00955	CcSEcCtD
Salicylic acid—SLC16A1—Hemostasis—F5—Crohn's disease	3.57e-05	0.00195	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	3.55e-05	0.00194	CbGpPWpGaD
Salicylic acid—Urticaria—Mesalazine—Crohn's disease	3.53e-05	0.00921	CcSEcCtD
Salicylic acid—AKR1C1—Metabolism—MTMR3—Crohn's disease	3.51e-05	0.00192	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TAGAP—Crohn's disease	3.45e-05	0.00189	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	3.4e-05	0.00186	CbGpPWpGaD
Salicylic acid—Diarrhoea—Azathioprine—Crohn's disease	3.34e-05	0.00871	CcSEcCtD
Salicylic acid—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	3.33e-05	0.00182	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.32e-05	0.00181	CbGpPWpGaD
Salicylic acid—Hallucination—Prednisone—Crohn's disease	3.29e-05	0.00859	CcSEcCtD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.25e-05	0.00178	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.25e-05	0.00178	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL17A—Crohn's disease	3.23e-05	0.00177	CbGpPWpGaD
Salicylic acid—Dizziness—Azathioprine—Crohn's disease	3.23e-05	0.00842	CcSEcCtD
Salicylic acid—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.17e-05	0.00173	CbGpPWpGaD
Salicylic acid—Pruritus—Mesalazine—Crohn's disease	3.15e-05	0.0082	CcSEcCtD
Salicylic acid—Vomiting—Azathioprine—Crohn's disease	3.1e-05	0.00809	CcSEcCtD
Salicylic acid—Rash—Azathioprine—Crohn's disease	3.08e-05	0.00803	CcSEcCtD
Salicylic acid—Dermatitis—Azathioprine—Crohn's disease	3.07e-05	0.00802	CcSEcCtD
Salicylic acid—Headache—Azathioprine—Crohn's disease	3.06e-05	0.00797	CcSEcCtD
Salicylic acid—Diarrhoea—Mesalazine—Crohn's disease	3.04e-05	0.00793	CcSEcCtD
Salicylic acid—AKR1C1—Signaling Pathways—RSPO3—Crohn's disease	3.02e-05	0.00165	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	3.01e-05	0.00165	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	3e-05	0.00164	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL12B—Crohn's disease	3e-05	0.00164	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	2.99e-05	0.00164	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	2.97e-05	0.00163	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—GCKR—Crohn's disease	2.95e-05	0.00162	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.95e-05	0.00161	CbGpPWpGaD
Salicylic acid—Dizziness—Mesalazine—Crohn's disease	2.94e-05	0.00767	CcSEcCtD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.93e-05	0.0016	CbGpPWpGaD
Salicylic acid—Nausea—Azathioprine—Crohn's disease	2.9e-05	0.00756	CcSEcCtD
Salicylic acid—Erythema—Prednisone—Crohn's disease	2.88e-05	0.00752	CcSEcCtD
Salicylic acid—AKR1C1—Signaling Pathways—SEL1L—Crohn's disease	2.86e-05	0.00157	CbGpPWpGaD
Salicylic acid—Vomiting—Mesalazine—Crohn's disease	2.83e-05	0.00737	CcSEcCtD
Salicylic acid—Rash—Mesalazine—Crohn's disease	2.8e-05	0.00731	CcSEcCtD
Salicylic acid—Dermatitis—Mesalazine—Crohn's disease	2.8e-05	0.0073	CcSEcCtD
Salicylic acid—Headache—Mesalazine—Crohn's disease	2.78e-05	0.00726	CcSEcCtD
Salicylic acid—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	2.78e-05	0.00152	CbGpPWpGaD
Salicylic acid—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	2.78e-05	0.00152	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.76e-05	0.00151	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	2.75e-05	0.0015	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—FADS1—Crohn's disease	2.74e-05	0.0015	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.73e-05	0.00149	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.72e-05	0.00149	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.71e-05	0.00148	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.71e-05	0.00148	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.65e-05	0.00145	CbGpPWpGaD
Salicylic acid—Nausea—Mesalazine—Crohn's disease	2.64e-05	0.00689	CcSEcCtD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	2.62e-05	0.00144	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCR9—Crohn's disease	2.62e-05	0.00143	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—SLC11A1—Crohn's disease	2.61e-05	0.00143	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.6e-05	0.00142	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—GPX4—Crohn's disease	2.56e-05	0.0014	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—GCKR—Crohn's disease	2.47e-05	0.00135	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	2.44e-05	0.00134	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	2.44e-05	0.00134	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—GPR65—Crohn's disease	2.43e-05	0.00133	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—CRP—Crohn's disease	2.43e-05	0.00133	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.41e-05	0.00132	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	2.39e-05	0.00131	CbGpPWpGaD
Salicylic acid—Oedema—Prednisone—Crohn's disease	2.35e-05	0.00613	CcSEcCtD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	2.33e-05	0.00128	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.31e-05	0.00126	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	2.31e-05	0.00126	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PLA2G4F—Crohn's disease	2.3e-05	0.00126	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.29e-05	0.00125	CbGpPWpGaD
Salicylic acid—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	2.27e-05	0.00125	CbGpPWpGaD
Salicylic acid—Anorexia—Prednisone—Crohn's disease	2.24e-05	0.00585	CcSEcCtD
Salicylic acid—AKR1C1—Disease—RBX1—Crohn's disease	2.24e-05	0.00123	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HSPA1B—Crohn's disease	2.24e-05	0.00123	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—ICAM1—Crohn's disease	2.24e-05	0.00122	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.19e-05	0.0012	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL10—Crohn's disease	2.19e-05	0.0012	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—ITGA4—Crohn's disease	2.19e-05	0.0012	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.16e-05	0.00118	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—IL3—Crohn's disease	2.14e-05	0.00117	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	2.1e-05	0.00115	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	2.09e-05	0.00114	CbGpPWpGaD
Salicylic acid—SLCO2B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.08e-05	0.00114	CbGpPWpGaD
Salicylic acid—Dyspepsia—Prednisone—Crohn's disease	2.07e-05	0.0054	CcSEcCtD
Salicylic acid—SLC16A1—Hemostasis—RASGRP1—Crohn's disease	2.07e-05	0.00113	CbGpPWpGaD
Salicylic acid—Decreased appetite—Prednisone—Crohn's disease	2.04e-05	0.00533	CcSEcCtD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.02e-05	0.00111	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.02e-05	0.0011	CbGpPWpGaD
Salicylic acid—Constipation—Prednisone—Crohn's disease	2.01e-05	0.00525	CcSEcCtD
Salicylic acid—AKR1C1—Disease—UBE2D1—Crohn's disease	1.96e-05	0.00107	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—MTMR3—Crohn's disease	1.96e-05	0.00107	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	1.96e-05	0.00107	CbGpPWpGaD
Salicylic acid—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.96e-05	0.00107	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.94e-05	0.00106	CbGpPWpGaD
Salicylic acid—Feeling abnormal—Prednisone—Crohn's disease	1.94e-05	0.00506	CcSEcCtD
Salicylic acid—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	1.93e-05	0.00106	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.91e-05	0.00105	CbGpPWpGaD
Salicylic acid—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.88e-05	0.00103	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	1.88e-05	0.00103	CbGpPWpGaD
Salicylic acid—Urticaria—Prednisone—Crohn's disease	1.87e-05	0.00487	CcSEcCtD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	1.86e-05	0.00102	CbGpPWpGaD
Salicylic acid—SLC16A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.84e-05	0.00101	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.83e-05	0.001	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	1.83e-05	0.001	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.82e-05	0.000994	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	1.81e-05	0.000991	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.8e-05	0.000985	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.78e-05	0.000972	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.77e-05	0.000968	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.74e-05	0.000955	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	1.74e-05	0.00095	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCR6—Crohn's disease	1.73e-05	0.000949	CbGpPWpGaD
Salicylic acid—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.73e-05	0.000946	CbGpPWpGaD
Salicylic acid—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.71e-05	0.000934	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IFNG—Crohn's disease	1.7e-05	0.000931	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	1.7e-05	0.00093	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.69e-05	0.000925	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.68e-05	0.000922	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	1.67e-05	0.000916	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	1.67e-05	0.000914	CbGpPWpGaD
Salicylic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.67e-05	0.000912	CbGpPWpGaD
Salicylic acid—Pruritus—Prednisone—Crohn's disease	1.66e-05	0.00434	CcSEcCtD
Salicylic acid—Diarrhoea—Prednisone—Crohn's disease	1.61e-05	0.0042	CcSEcCtD
Salicylic acid—AKR1C1—Signaling Pathways—RBX1—Crohn's disease	1.57e-05	0.000858	CbGpPWpGaD
Salicylic acid—Dizziness—Prednisone—Crohn's disease	1.56e-05	0.00406	CcSEcCtD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.55e-05	0.000847	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTGER4—Crohn's disease	1.53e-05	0.000835	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—FADS1—Crohn's disease	1.53e-05	0.000835	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL1B—Crohn's disease	1.52e-05	0.00083	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—IL2RA—Crohn's disease	1.5e-05	0.00082	CbGpPWpGaD
Salicylic acid—Vomiting—Prednisone—Crohn's disease	1.5e-05	0.0039	CcSEcCtD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	1.49e-05	0.000815	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.48e-05	0.000812	CbGpPWpGaD
Salicylic acid—Rash—Prednisone—Crohn's disease	1.48e-05	0.00387	CcSEcCtD
Salicylic acid—Dermatitis—Prednisone—Crohn's disease	1.48e-05	0.00386	CcSEcCtD
Salicylic acid—Headache—Prednisone—Crohn's disease	1.47e-05	0.00384	CcSEcCtD
Salicylic acid—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.43e-05	0.000785	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GPX4—Crohn's disease	1.43e-05	0.000782	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.43e-05	0.000782	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.43e-05	0.000781	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.41e-05	0.000772	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.41e-05	0.000772	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—SMAD3—Crohn's disease	1.4e-05	0.000769	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	1.4e-05	0.000766	CbGpPWpGaD
Salicylic acid—Nausea—Prednisone—Crohn's disease	1.4e-05	0.00364	CcSEcCtD
Salicylic acid—SLC16A1—Metabolism—GCKR—Crohn's disease	1.38e-05	0.000755	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.38e-05	0.000754	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—UBE2D1—Crohn's disease	1.37e-05	0.000752	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	1.36e-05	0.000745	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	1.35e-05	0.000741	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	1.35e-05	0.00074	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	1.35e-05	0.000739	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.34e-05	0.000732	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RIPK2—Crohn's disease	1.33e-05	0.00073	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	1.32e-05	0.000723	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL3—Crohn's disease	1.3e-05	0.000712	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.3e-05	0.000709	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IFNG—Crohn's disease	1.29e-05	0.000706	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RASGRP1—Crohn's disease	1.26e-05	0.000688	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.24e-05	0.000676	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.24e-05	0.000676	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.23e-05	0.000672	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.21e-05	0.000664	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.21e-05	0.000662	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.21e-05	0.00066	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—F5—Crohn's disease	1.2e-05	0.000659	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	1.2e-05	0.000657	CbGpPWpGaD
Salicylic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.2e-05	0.000655	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.18e-05	0.000645	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.16e-05	0.000632	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL1B—Crohn's disease	1.15e-05	0.00063	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SOCS1—Crohn's disease	1.14e-05	0.000623	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TNF—Crohn's disease	1.1e-05	0.000602	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.1e-05	0.000601	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.09e-05	0.000598	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—ALB—Crohn's disease	1.08e-05	0.000593	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.08e-05	0.000592	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.08e-05	0.000592	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.06e-05	0.000577	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—MTMR3—Crohn's disease	1.03e-05	0.000563	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—JAK2—Crohn's disease	1.01e-05	0.000551	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RSPO3—Crohn's disease	1e-05	0.000549	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.94e-06	0.000544	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SMAD3—Crohn's disease	9.84e-06	0.000538	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	9.8e-06	0.000537	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PLA2G4F—Crohn's disease	9.6e-06	0.000526	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	9.56e-06	0.000523	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SEL1L—Crohn's disease	9.5e-06	0.00052	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.46e-06	0.000518	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—ALB—Crohn's disease	9.37e-06	0.000513	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—TYK2—Crohn's disease	9.16e-06	0.000501	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2RA—Crohn's disease	9.11e-06	0.000498	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL6—Crohn's disease	8.88e-06	0.000486	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.86e-06	0.000485	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.78e-06	0.000481	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	8.74e-06	0.000479	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—JAK2—Crohn's disease	8.74e-06	0.000478	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	8.72e-06	0.000477	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.71e-06	0.000477	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	8.67e-06	0.000475	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	8.55e-06	0.000468	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—LTF—Crohn's disease	8.52e-06	0.000466	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TNF—Crohn's disease	8.35e-06	0.000457	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CD4—Crohn's disease	8.29e-06	0.000454	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PTGS2—Crohn's disease	8.23e-06	0.00045	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—MTMR3—Crohn's disease	8.17e-06	0.000447	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—FADS1—Crohn's disease	8.01e-06	0.000439	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—ALB—Crohn's disease	7.87e-06	0.000431	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PLA2G4F—Crohn's disease	7.77e-06	0.000425	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.7e-06	0.000421	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GPX4—Crohn's disease	7.5e-06	0.000411	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—ITGA4—Crohn's disease	7.4e-06	0.000405	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	7.29e-06	0.000399	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GCKR—Crohn's disease	7.25e-06	0.000397	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL3—Crohn's disease	7.21e-06	0.000395	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	7.06e-06	0.000386	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RASGRP1—Crohn's disease	6.98e-06	0.000382	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	6.9e-06	0.000378	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTGS2—Crohn's disease	6.89e-06	0.000377	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GCKR—Crohn's disease	6.87e-06	0.000376	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PLA2G4F—Crohn's disease	6.81e-06	0.000373	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—MTMR3—Crohn's disease	6.61e-06	0.000362	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	6.59e-06	0.000361	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TYK2—Crohn's disease	6.42e-06	0.000351	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—STAT3—Crohn's disease	6.42e-06	0.000351	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—FADS1—Crohn's disease	6.36e-06	0.000348	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	6.36e-06	0.000348	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—JAK2—Crohn's disease	6.12e-06	0.000335	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	6.11e-06	0.000334	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	6.08e-06	0.000333	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SLC11A1—Crohn's disease	6.07e-06	0.000332	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GPX4—Crohn's disease	5.96e-06	0.000326	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.81e-06	0.000318	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—MTMR3—Crohn's disease	5.79e-06	0.000317	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GCKR—Crohn's disease	5.75e-06	0.000315	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL8—Crohn's disease	5.59e-06	0.000306	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—MTMR3—Crohn's disease	5.41e-06	0.000296	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RBX1—Crohn's disease	5.21e-06	0.000285	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HSPA1B—Crohn's disease	5.21e-06	0.000285	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.18e-06	0.000283	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—FADS1—Crohn's disease	5.15e-06	0.000282	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2RA—Crohn's disease	5.05e-06	0.000277	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPX4—Crohn's disease	4.82e-06	0.000264	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GCKR—Crohn's disease	4.65e-06	0.000255	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—UBE2D1—Crohn's disease	4.56e-06	0.00025	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.53e-06	0.000248	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—FADS1—Crohn's disease	4.51e-06	0.000247	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—Crohn's disease	4.49e-06	0.000246	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—Crohn's disease	4.48e-06	0.000245	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ALB—Crohn's disease	4.39e-06	0.00024	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPX4—Crohn's disease	4.22e-06	0.000231	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—FADS1—Crohn's disease	4.21e-06	0.000231	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.12e-06	0.000226	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.11e-06	0.000225	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GCKR—Crohn's disease	4.08e-06	0.000223	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPX4—Crohn's disease	3.94e-06	0.000216	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—Crohn's disease	3.84e-06	0.00021	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GCKR—Crohn's disease	3.81e-06	0.000208	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—JAK2—Crohn's disease	3.4e-06	0.000186	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SMAD3—Crohn's disease	3.27e-06	0.000179	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—Crohn's disease	3.14e-06	0.000172	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.91e-06	0.000159	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.77e-06	0.000152	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.72e-06	0.000149	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.38e-06	0.00013	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALB—Crohn's disease	2.31e-06	0.000126	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TYK2—Crohn's disease	2.13e-06	0.000117	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—JAK2—Crohn's disease	2.03e-06	0.000111	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—Crohn's disease	2.02e-06	0.00011	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD4—Crohn's disease	1.93e-06	0.000105	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALB—Crohn's disease	1.83e-06	0.0001	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—Crohn's disease	1.49e-06	8.16e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALB—Crohn's disease	1.3e-06	7.1e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—Crohn's disease	1.3e-06	7.09e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALB—Crohn's disease	1.21e-06	6.64e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—Crohn's disease	1.14e-06	6.21e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.06e-06	5.81e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—Crohn's disease	1.04e-06	5.7e-05	CbGpPWpGaD
